top of page
Search

First-ever withdrawal drug could vault more patients into MAT

Updated: Mar 27, 2023









FDA chief: First-ever withdrawal drug could vault more patients into addiction therapy



Patients who go off opioid painkillers face excruciating withdrawal symptoms such as anxiety, nausea, vomiting, insomnia, muscle aches and more. Now, thanks to an FDA approval for US WorldMeds' Lucemyra, they'll have the first drug designed to fight those symptoms.



Comments


bottom of page